News and Comments

IDERA (IDRA): GOOD NEWS OFFSET SOMEWHAT BY SKEPTICISM NOT PESSIMISM

  Monday, March 04, 2013

Forgetting about Idera Pharmaceuticals (IDRA) seems to make its value sink, but failed to make it disappear. With a stock that sells at less than a three quarter of a dollar and a market of $20 million, lower than a new comer biotech having drugs still in preclinical lab testing, the firm was capable of drawing investors’ attention, riding new data about an attractive possibility of beating all existing approaches to treating psoriasis. The surprising data, which bring hopes in treating other autoimmune diseases, in addition to psoriasis were presented by James G. Krueger, M.D., PhD, of The Rockefeller University, at the Late-Breaking Research Symposium on March 2nd, 2013, during the American Academy of Dermatology Annual Meeting. More...


Recent Postings


Archive


Tags

Revlimid (lenolidamide) Genentech Pluristem (PSTI) Gilead (GILD) BIOMARIN (BMRN) Inovio (INO) Bristol-Myers Squibb (BMY) Agenus (AGEN Vitae Pharmaceuticals (VTAE) Ziofpharm (ZIOP) Vertex (VRTX) NANTKWEST (NK) ACADIA (ACAD) Aimmune Therapeutics (AIMT) MODERNA Anadys (ANDS) ADVENTRIX (ANX) IDERA (IDRA) Bellicum (BLCM) Dendreon (DNDN) Xoma (XOMA) Multiple Myeloma Sarepta (SRPT) INNOVIVA (INVA) PTC Therapeutics (PTCT) SERES THERAPEUTICS (MCRB) Ocular Therapeutix (OCUL) Idenix (IDIX) Illumina (ILMN) Sanofi (SNY) Valeant Pharmaceuticals International (VRX) Human Genome Sciences (HGSI) CEMPRA (CEMP) Elan (ELN) TOKAI (TKAOI) Advaxis (ADXS) Auspex (ASPX) Onyx (ONXX) NOVOCURE (NVCR) Global Cell Therapeutics (GBT) JUNO (JUNO) AERIE PHARMACEUTICALS ZALTRAP™ KITE (KITE) Prosensa (RNA) Rapamune Regeneron (REGN) Sanofi (SNA) Exelixis (EXEL) KERYX (KERX) Prolor Biotech (PBTH) Human Longevity (HLI) Ridaforolimus Roche (ROCHE) Ariad (ARIA) REGULUS (RGLS) OSI (OSIP) Agenus (AGEN) Velcade (bortezomib) Tysabri Merck (MRK) ARCA (ABIO) Intrexon (XON) HALOZYME (HALO) Zerenex NEKTAR (NKTR)) Cytokinetics (CYTK) Incyte (INCY) Sequenom (SQNM) Micromet (MITI) Alder Biopharmaceuticals (ALDR) VANDA (VNDA) Sangamo (SGMO) CRISPR Therapeutics (CRSP) RenenxBio (RGNX) Intercept (ICPT) CompuGen (CGEN) Spike Therapeutics (ONCE) galapagos (GLPG) Mirati Therapeutics (MRTX) Array Pharmaceuticals (ARRY) SUNESIS PHARMACEUTICALS (SNSS) ABBVIE (ABBV) Herceptin Telaprevir Theravance (THRX) PORTOLA (PTLA) Galena (GALE) Adaptimmune (ADAP) Ionis (IONS) Intermune (ITMN) AGOS (ARGS) Amgen (AMGN) ARGOS (ARGS) Alnylam (ALNY) Editas (EDIT) Seattle Genetics (SGEN) Jazz Pharmaceuticals (JAZZ) Dynavax (DVAX) GUARDIAN HEALTH C4 Therapeutics Roche (RHHBY) Benlysta (belimumab) ISIS (ISIS) Biogen Idec (BIIB) Abbott Laboratories (ABT) Sanofi-Aventis (SAN) Biocryst (BCRX) AstraZeneca (AZN) SYNTA (SNTA) GlaxoSmithKline (GSK) Theravance Bio Pharma (TBPH) Anacor (ANAC) ImmunoGen (IMGN) Trastuzumab-DM1 Endometrial Cancer